Tracking immune markers in newborns at risk for eczema
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This study follows newborns for two years to see how their immune system develops, especially if they have a family history of eczema, asthma, or hay fever. Researchers want to learn if certain immune markers appear early in babies who later develop eczema.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Baby is born at UZ Brussel hospital in Belgium
- At least one parent or sibling has eczema, asthma, or hay fever (high-risk group)
- Parent speaks Dutch, French, or English well enough to understand the study
- Baby is born at 34 weeks or later and does not need intensive care after birth
- Family is able to attend study visits for two years
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special baby formula (partially broken-down protein with added prebiotics and probiotics) to see if it helps strengthen babies' skin barrier and reduce allergy risk. It's designed for newborns who have a family history of allergies.
This Phase 2 study tests a treatment called IgE-specific immunoadsorption, which works by filtering certain immune signals in the blood. It is meant for adults with severe, long-lasting eczema that has not responded well (or could not be tolerated) to standard treatments.
This observational study follows people with eczema (atopic dermatitis) and sometimes related allergies over time, even if they keep their usual medical treatments. It may help researchers better understand how these conditions change and what factors relate to symptoms.
This study is testing whether special skin care routines in the first year of life can help prevent allergies and skin problems in babies who are at higher risk. It might be a good fit if your baby is a healthy full-term newborn and has at least one risk factor, like being an only child or having a family history of allergies or asthma.
This study looks at tiny skin samples from babies to find clues about eczema. It uses a gentle, painless device that sucks up a small piece of skin. If your baby has eczema or is healthy and under 6 months old, you may be able to join.
This study looks at the types of germs on the skin (skin microbiome) in healthy people and people with skin conditions, including atopic dermatitis (eczema). Researchers collect skin samples to understand how skin germs differ and how that may relate to skin health.
Hear when a new Microbiome, Human trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.